2C-T-2 (2,5-dimethoxy-4-ethylthiophenethylamine) is a psychedelic phenethylamine from Alexander Shulgin's thio-substituted 2C series -- a family of compounds that proved both fascinating and deadly. Documented as entry #39 in PiHKAL (1991), 2C-T-2 is the 4-ethylthio analog: replace the propyl chain of 2C-T-7 with a shorter ethyl group, and you get a slightly more potent compound (active at 12-25 mg oral) with a shorter duration (6-8 hours) but the same fundamental pharmacological gamble. Shulgin found it rewarding -- warm, visual, gently empathogenic -- and documented generally positive experiences. The broader world's experience was less kind.
The sulfur atom that distinguishes all 2C-T compounds from their safer cousins (2C-B, 2C-I, 2C-E) is the source of both their unique character and their danger. That thio group creates substrate interactions with monoamine oxidase enzymes, introducing a metabolic unpredictability that does not exist in halogenated or alkyl-substituted phenethylamines. The practical consequence is that individual responses to the same dose can vary dramatically -- one person gets a beautiful evening of warm visuals and emotional openness, another develops tachycardia, hypertension, and features of serotonin toxicity. Multiple deaths and severe adverse events were attributed to 2C-T-2 in the early 2000s, most involving high doses or combination with other serotonergic substances.
What people who have used 2C-T-2 report, when things go right, is genuinely appealing: a moderate psychedelic experience with unusually warm visual character, a pleasant empathogenic quality that facilitates emotional connection without the overwhelming serotonin dump of MDMA, and a sensual enhancement of touch and texture that is distinctive to the thio-2C series. The nausea during the come-up is notorious -- more pronounced than with most phenethylamines -- but generally resolves as the psychedelic effects establish themselves. The overall character has been described as a gentler, shorter cousin of 2C-T-7 with less headspace depth but more social warmth.
None of which changes the calculus. 2C-B produces a comparable experience at similar doses without the MAO-mediated toxicity risk, without the fatality record, and without the metabolic Russian roulette of individually variable MAO expression. The harm reduction consensus is clear: 2C-T-2 does not offer enough over safer alternatives to justify its risk profile.
Safety at a Glance
High Risk- Combinations That Are Dangerous or Lethal
- SSRIs and SNRIs: Impaired serotonin clearance through the same MAO interaction pathway. Contraindicated
- Toxicity: Documented Fatalities Multiple deaths have been attributed to 2C-T-2 in the medical and forensic literature. The fata...
- Overdose risk: Recognizing a 2C-T-2 Emergency 2C-T-2 belongs to a family of compounds with documented fatalities...
If someone is in crisis, call 911 or Poison Control: 1-800-222-1222
Dosage
insufflated
oral
Duration
insufflated
Total: 3 hrs – 7 hrsoral
Total: 6 hrs – 10 hrsHow It Feels
The stomach knows first. Within thirty to forty-five minutes, a queasy warmth settles into the abdomen -- not the gentle flutter of a mushroom come-up but a more insistent gastrointestinal protest that is the signature of thio-substituted phenethylamines. The nausea can be genuinely unpleasant for the first hour, ranging from a persistent queasiness that discourages movement to waves intense enough to send people to the bathroom. Ginger tea beforehand helps. A light meal two hours prior helps more. Alongside the nausea, the world starts to brighten at the edges. Colors warm. The light in the room takes on a golden quality, as though someone has adjusted the white balance toward sunset.
By the seventy-five-minute mark, the nausea is usually retreating and the psychedelic effects are establishing their full character. This is where 2C-T-2 becomes distinctive. The visual field fills with warm, flowing geometry -- surfaces breathe gently, patterns ripple across walls and fabrics with an organic quality, and the color palette shifts toward ambers, golds, and deep warm tones that give the world a luminous, honeyed quality. The visuals are moderate in intensity -- less overwhelming than 2C-E, less crisp and digital than 2C-I -- and have a softness that feels inviting rather than demanding. Objects do not fragment or dissolve; they glow and pulse and seem more present than usual.
The headspace carries a warmth that is one of the compound's most distinctive features. There is an empathogenic quality -- not the jaw-clenching serotonin surge of MDMA, but a quiet softening of emotional defenses that makes conversations feel meaningful and connection feel easy. Social interactions acquire a depth and sincerity that people compare to a low dose of MDMA layered over a moderate psychedelic. Introspection is present but not demanding -- you can choose to go inward, but the experience does not drag you there the way 2C-T-7 or psilocybin might. Music is beautifully enhanced, acquiring emotional resonance and a physical presence you can almost feel in your chest. Touch becomes extraordinary -- fabrics feel alive with texture, skin becomes hypersensitive to temperature and pressure, and there is a sensual quality to physical sensation that is one of the thio-2C series' most reported features.
The body, once past the nausea, settles into a state of relaxed alertness. There is a mild stimulant energy that keeps you engaged without producing the restless drive of amphetamine-type stimulation. Movement feels fluid. The peak lasts two to four hours, and total effects span six to eight hours -- one of the shorter experiences in the 2C family, which many users consider an advantage. The descent is smooth and comfortable, visuals fading while the emotional warmth and sensory enhancement linger. The afterglow is clean -- mild fatigue, perhaps, but no harsh comedown, no grinding residual stimulation, no emotional flatness. Most people can sleep within a few hours of the end and wake feeling normal.
Subjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Physical(13)
- Bodily control enhancement— Bodily control enhancement is the subjective feeling of improved physical precision, coordination, a...
- Diarrhea— Diarrhea is the occurrence of frequent, loose, or watery bowel movements as a side effect of certain...
- Increased bodily temperature— Increased bodily temperature (hyperthermia) is an elevation of core body temperature above the norma...
- Increased heart rate— A noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a fo...
- Muscle twitching— Muscle twitching consists of small, involuntary, localized contractions or tremors within individual...
- Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
- Physical euphoria— An intensely pleasurable bodily sensation that can manifest as waves of warmth, tingling electricity...
- Pupil dilation— A visible enlargement of the pupil diameter (mydriasis) that can range from subtle widening to drama...
- Serotonin syndrome— Serotonin syndrome is a potentially fatal medical emergency caused by excessive serotonergic activit...
- Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
- Stomach cramp— Stomach cramps are sharp, intermittent pains in the abdominal region that can occur when psychoactiv...
- Temperature regulation disruption— Impaired thermoregulation causing unpredictable fluctuations between feeling hot and cold, with risk...
- Vasoconstriction— A narrowing of blood vessels throughout the body that produces sensations of cold extremities, tingl...
Tactile(1)
- Tactile enhancement— The sense of touch becomes dramatically heightened, making physical contact feel intensely pleasurab...
Cognitive & Perceptual Effects
Visual(16)
- After images— A visual phenomenon in which a faint, ghostly imprint of a previously viewed image persists in the v...
- Autonomous entity— The perception of contact with seemingly sentient, independently acting beings that appear within ha...
- Colour enhancement— An intensification of the brightness, vividness, and saturation of colors in the external environmen...
- Colour shifting— The visual experience of colors on objects and surfaces cycling through continuous, fluid transforma...
- Drifting— The visual experience of perceiving stationary objects, textures, and surfaces as appearing to flow,...
- External hallucination— A visual hallucination that manifests within the external environment as though it were physically r...
- Geometry— The experience of perceiving complex, ever-shifting geometric patterns superimposed over the visual ...
- Internal hallucination— Vivid, detailed visual experiences perceived within an imagined mental landscape that can only be se...
- Pattern recognition enhancement— An increased ability and tendency to perceive meaningful patterns, faces, and images within ambiguou...
- Perspective hallucination— A hallucinatory phenomenon in which the observer's visual perspective shifts from the normal first-p...
- Scenery slicing— The visual field fractures into distinct, cleanly cut sections that slowly drift apart from their or...
- Settings, sceneries, and landscapes— The perceived environment in which hallucinatory experiences take place, ranging from recognizable l...
- Symmetrical texture repetition— Textures appear to mirror and tessellate across surfaces in intricate, self-similar symmetrical patt...
- Tracers— Moving objects leave visible trails of varying length and opacity behind them, similar to long-expos...
- Transformations— Objects and scenery undergo perceived visual metamorphosis, smoothly shapeshifting into other recogn...
- Visual acuity enhancement— Vision becomes sharper and more defined than normal, as though a slightly blurry lens has been broug...
Cognitive(15)
- Analysis enhancement— A perceived improvement in one's ability to logically deconstruct concepts, recognize patterns, and ...
- Conceptual thinking— A shift in the nature of thought from verbal, linear sentence structures to intuitive, non-linguisti...
- Confusion— An impairment of abstract thinking marked by a persistent inability to grasp or comprehend concepts ...
- Delusion— A delusion is a fixed, false belief that is held with unshakeable certainty and is impervious to con...
- Empathy enhancement— A state of intensified compassion and emotional openness in which one feels deeply connected to othe...
- Immersion enhancement— A heightened capacity to become fully absorbed and engrossed in external media such as music, films,...
- Increased sense of humor— A general amplification of one's sensitivity to finding things humorous and amusing, often causing p...
- Introspection— An enhanced state of self-reflective awareness in which one feels drawn to examine their own thought...
- Memory suppression— A dose-dependent inhibition of one's ability to access and utilize short-term and long-term memory, ...
- Novelty enhancement— A feeling of increased fascination, awe, and childlike wonder attributed to everyday concepts, objec...
- Personal bias suppression— A decrease in the personal, cultural, and cognitive biases through which one normally filters their ...
- Thought acceleration— The experience of thoughts occurring at a dramatically increased rate, as if the mind has been shift...
- Thought loops— Becoming trapped in a repeating cycle of thoughts, actions, and emotions that loops every few second...
- Time distortion— Subjective perception of time becomes dramatically altered — minutes may feel like hours, or hours p...
- Wakefulness— An increased ability to stay awake and alert without the desire to sleep. Distinct from stimulation ...
Multi-sensory(1)
- Scenarios and plots— Scenarios and plots are the narrative structures that emerge within hallucinatory states — coherent ...
Transpersonal(5)
- Ego death— A profound dissolution of the sense of self in which personal identity, memories, and the boundary b...
- Entity contact— Perception of encountering autonomous beings or presences during psychedelic states, ranging from va...
- Existential self-realization— A sudden, visceral realization of the profound significance and improbability of one's own existence...
- Perception of interdependent opposites— Perception of interdependent opposites is the profound, felt realization that reality is structured ...
- Unity and interconnectedness— A profound sense that identity extends beyond the self to encompass other people, nature, or all of ...
Pharmacology
Mechanism of Action
2C-T-2 produces its psychedelic effects through partial agonism at serotonin 5-HT2A receptors -- the universal mechanism shared by all classical psychedelics. It also shows affinity at 5-HT2C receptors, contributing to mood effects and the potential for anxiety at higher doses. The ethylthio substituent at C4 provides moderate-to-good receptor affinity, making 2C-T-2 slightly more potent by weight than its propylthio cousin 2C-T-7 (active at 12-25 mg versus 10-30 mg), consistent with the general observation that shorter alkyl chains on the thio group tend to increase binding affinity in this series.
The MAO Problem
The critical pharmacological distinction between 2C-T-2 and non-thio 2C compounds is the sulfur atom. Replace the sulfur with a halogen (as in 2C-B or 2C-I) or a simple alkyl group (as in 2C-D), and you get compounds that are metabolized predictably by standard hepatic pathways. Keep the sulfur, and you introduce substrate interaction with monoamine oxidase (MAO) -- the enzyme family responsible for degrading monoamine neurotransmitters including serotonin.
This interaction creates a cascade of pharmacological problems:
- Self-inhibited metabolism -- 2C-T-2 may partially inhibit the enzyme responsible for its own breakdown. At lower doses, this may be clinically insignificant. At higher doses, it can cause nonlinear accumulation -- the drug builds up faster than the body can clear it, and the dose-response curve becomes dangerously steep
- Amplified serotonergic effects -- Any co-administered substance that increases serotonin levels (SSRIs, SNRIs, MAOIs, MDMA, DXM, triptans) faces impaired clearance through 2C-T-2's MAO interaction, creating conditions for serotonin syndrome
- Genetic variability -- MAO enzyme expression varies significantly between individuals based on genotype. Two people taking identical doses of 2C-T-2 may experience dramatically different pharmacokinetic profiles, making dose-response prediction fundamentally unreliable
Pharmacokinetics
Oral onset occurs at 45-75 minutes, with peak effects at 1.5-3 hours and total duration of 6-8 hours. The shorter duration compared to 2C-T-7 (8-12 hours) likely reflects faster metabolic clearance of the ethyl versus propyl chain. Intranasal administration compresses onset to 10-20 minutes with significantly higher peak plasma levels -- a route associated with increased adverse events across the thio-2C series.
Comparison to 2C-B
The most relevant pharmacological comparison is to 2C-B (4-bromo-2,5-dimethoxyphenethylamine). Both compounds target 5-HT2A receptors at similar potencies and produce visual, empathogenic psychedelic experiences in similar dose ranges. The decisive difference is metabolic: 2C-B's bromine substituent creates no MAO interaction, no self-inhibited metabolism, and no individual variability in clearance. This is why 2C-B has never killed anyone and 2C-T-2 has.
Detection Methods
Urine Detection
2C-T-2 is not specifically targeted by standard immunoassay-based urine drug panels. However, because 2C-x phenethylamines share structural features with amphetamines, they may trigger false positives on amphetamine immunoassays in some cases. The likelihood of cross-reactivity depends on the specific immunoassay manufacturer and the antibody selectivity used. Urine detection windows for 2C-T-2 are estimated at 24 to 72 hours following ingestion when analyzed by LC-MS/MS methods, though limited pharmacokinetic data exists for many 2C-x compounds.
Blood and Serum Detection
Blood detection windows for 2C-T-2 are approximately 6 to 24 hours after oral administration. Peak plasma concentrations typically occur 1 to 3 hours post-ingestion. The relatively short half-lives of most 2C-x phenethylamines mean that blood testing must be performed promptly to capture detectable concentrations. LC-MS/MS is the only reliable method for quantitative blood analysis.
Standard Drug Panel Inclusion
2C-T-2 is NOT specifically included on standard 5-panel, 10-panel, or 12-panel drug screens. The primary concern for individuals undergoing routine screening is the potential for amphetamine cross-reactivity on immunoassay-based panels. If a presumptive positive for amphetamines occurs, confirmatory testing by GC-MS or LC-MS/MS would not confirm amphetamine and the result would be reported as negative unless the laboratory specifically tests for 2C-x compounds. Most routine laboratories do not include 2C-x phenethylamines in their confirmatory panels.
Confirmatory Methods
Definitive identification of 2C-T-2 requires LC-MS/MS or GC-MS with appropriate reference standards. Some forensic toxicology laboratories include 2C-x phenethylamines in their extended novel psychoactive substance panels. Immunoassay cross-reactivity alone is insufficient for confirmation and would be resolved by standard confirmatory procedures. Quantitative analysis typically requires specific method development as these compounds are not part of routine clinical chemistry workflows.
Reagent Testing (Harm Reduction)
For harm reduction identification, the Marquis reagent is a primary screening tool for 2C-T-2. The Marquis reagent produces a brown to olive reaction with 2C-T-2. The Mecke reagent may show a dark brown to black reaction specific to thio-substituted phenethylamines. The Mecke reagent may provide additional color reactions that help differentiate between specific 2C-x variants. The Ehrlich reagent shows no reaction with 2C-x phenethylamines, which can help distinguish them from tryptamines and lysergamides. The Mandelin reagent may produce green to brown reactions depending on the specific compound. Using multiple reagents in combination provides the most reliable field identification, though reagent testing cannot determine purity or dosage.
Interactions
| Substance | Status | Note |
|---|---|---|
| 2-Aminoindane | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2-FA | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2-FEA | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2-FMA | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2,5-DMA | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 1,3-Butanediol | Low Risk & Synergy | Cross-tolerance exists; effects compound |
| 1B-LSD | Low Risk & Synergy | Cross-tolerance exists; effects compound |
| 1cP-AL-LAD | Low Risk & Synergy | Cross-tolerance exists; effects compound |
| 1cP-LSD | Low Risk & Synergy | Cross-tolerance exists; effects compound |
| 1cP-MiPLA | Low Risk & Synergy | Cross-tolerance exists; effects compound |
History
2C-T-2 emerged from Alexander Shulgin's laboratory as part of his systematic exploration of sulfur-containing phenethylamine analogs in the 1980s. The compound appears as entry #39 in PiHKAL: A Chemical Love Story (1991), where Shulgin documented a dose range of 12-25 mg, a duration of 6-8 hours, and generally positive subjective experiences. He described 2C-T-2 as producing a warm, colorful psychedelic state with notable empathogenic qualities. At the time of publication, the compound had been tested by only a small number of people in Shulgin's research group, and no serious adverse effects had been observed in that carefully controlled context.
Through the 1990s, 2C-T-2 circulated in small quantities among the psychedelic community, primarily through personal networks and early online forums. The compound developed a modest following among experienced psychonauts who appreciated its warm visual character and social qualities. When the first wave of online research chemical vendors emerged in the late 1990s, 2C-T-2 became commercially available in a legal gray area -- sold as "not for human consumption" by companies operating out of various jurisdictions where it was not yet explicitly scheduled.
The early 2000s brought catastrophe. Deaths attributed to 2C-T-2 and its close relative 2C-T-7 generated intense media coverage and regulatory scrutiny. The fatalities -- occurring primarily among young people at parties or in unsupervised settings -- involved high doses, combinations with other serotonergic substances, and clinical presentations consistent with serotonin syndrome and cardiovascular toxicity. These deaths were among the first widely publicized fatalities linked to the emerging category of "research chemicals" and fundamentally altered the regulatory landscape.
In the United States, 2C-T-2 was placed in Schedule I of the Controlled Substances Act. Internationally, it was controlled under the UK's Misuse of Drugs Act, the EU's various national analog and precursor laws, and similar legislation in Canada, Australia, and Japan. The scheduling of 2C-T-2 and its thio-substituted relatives was part of a broader wave of research chemical regulation that reshaped how governments approached novel psychoactive substances.
The historical significance of 2C-T-2 extends beyond its own pharmacology. The 2C-T fatalities collectively established a critical principle in harm reduction: that structural analogs of well-characterized compounds can carry dramatically different risk profiles, and that safety data from Shulgin's small, experienced bioassay group could not be extrapolated to a larger, less careful population. This lesson remains central to how the harm reduction community evaluates new psychoactive substances.
Harm Reduction
Risk Assessment
2C-T-2 has been implicated in fatalities. Safer psychedelic alternatives exist -- 2C-B in particular produces a remarkably similar experience profile (warm visuals, empathogenic quality, sensory enhancement, similar dose range) without the MAO-mediated toxicity risk. The existence of 2C-B functionally eliminates the argument for using 2C-T-2.
Combinations That Are Dangerous or Lethal
- MAOIs (prescription: phenelzine, tranylcypromine, moclobemide; herbal: Syrian rue, Banisteriopsis caapi, harmaline): Dramatically potentiated serotonergic effects, severe serotonin syndrome risk. Absolutely contraindicated
- SSRIs and SNRIs: Impaired serotonin clearance through the same MAO interaction pathway. Contraindicated
- MDMA: Massive serotonin release into a system with compromised clearance. Implicated in fatalities across the 2C-T series. Absolutely contraindicated
- DXM (dextromethorphan): Serotonin reuptake inhibition layered onto 2C-T-2's MAO interaction. Documented lethal with 2C-T-7; same mechanism applies. Absolutely contraindicated
- Triptans (sumatriptan, etc.): Serotonin agonists with serotonin syndrome risk when combined with MAO-interacting substances. Contraindicated
- Lithium: Increased psychosis and seizure risk with psychedelics. Contraindicated
- Tramadol: Seizure threshold reduction plus serotonin reuptake inhibition. Contraindicated
Route of Administration
Intranasal use produces faster onset, higher peak concentrations, and more adverse events. It also causes severe nasal pain and tissue damage. Oral administration is the only route with any published experiential data informing dose ranges. Never insufflate.
If Someone Chooses to Use
- Start at 10 mg or below. Do not trust dose recommendations from anonymous online sources
- Use a milligram-accurate scale. Volumetric dosing is the minimum acceptable standard for this potency range
- Have a sober, informed person present for the full 8+ hour experience
- Be within reach of emergency medical services
- Do not combine with any other psychoactive substance, including alcohol and cannabis
- Do not redose during the experience. The slow onset (75+ minutes) tempts people into dangerous dose stacking
Serotonin Syndrome Recognition
- Mild: Agitation, dilated pupils, sweating, tremor, rapid heartbeat, diarrhea
- Moderate: Muscle twitching (especially in the legs), hyperreflexia, fever above 38°C, disorientation
- Severe: Sustained rigid muscles, temperature above 41°C, seizures, delirium, cardiovascular collapse
Any symptoms beyond mild warrant an immediate call to emergency services. Serotonin syndrome escalates rapidly and can become fatal within hours. Begin cooling measures while waiting for help.
Toxicity & Safety
Documented Fatalities
Multiple deaths have been attributed to 2C-T-2 in the medical and forensic literature. The fatalities, occurring primarily in the early 2000s, were instrumental in establishing the 2C-T family as significantly more hazardous than the non-thio 2C compounds. Postmortem analyses revealed clinical features consistent with serotonin syndrome and acute cardiovascular toxicity. The deaths involved:
- Doses at or above the upper end of Shulgin's documented active range
- Combination with other serotonergic substances (MDMA, DXM, MAOIs)
- Features of serotonin toxicity: hyperthermia, seizures, cardiovascular collapse
Serotonin Toxicity
The MAO interaction inherent to 2C-T-2's thio-substitution creates a fundamentally different risk profile from non-thio psychedelics. At high doses or with serotonergic co-administration, the compound's dual action -- direct 5-HT2A agonism plus impaired serotonin clearance via MAO interaction -- can produce serotonin syndrome. Severe cases present with hyperthermia exceeding 41°C, sustained muscular rigidity, rhabdomyolysis, disseminated intravascular coagulation, and multi-organ failure. This risk exists at doses within the recreational range for individuals with low MAO enzyme expression and is dramatically amplified by any serotonergic combination.
Cardiovascular Effects
2C-T-2 produces more pronounced cardiovascular effects than non-thio 2C compounds. Reported effects include significant tachycardia, hypertension, and peripheral vasoconstriction. For individuals with pre-existing cardiovascular conditions -- including undiagnosed arrhythmias, valvular defects, or hypertension -- these effects represent independent risk factors separate from serotonin toxicity.
The Variability Problem
The most insidious aspect of 2C-T-2's toxicity is the individual variability in response. Because the thio group's interaction with MAO is modulated by an individual's genetically determined MAO enzyme expression, the same dose produces dramatically different pharmacokinetic profiles across individuals. A dose that is merely moderate for one person may be dangerously high for another. This variability makes "start low" insufficient as a safety strategy -- even conservative doses carry unpredictable risk.
Comparison to Non-Thio 2C Compounds
For context: 2C-B, 2C-I, 2C-E, and 2C-D -- compounds with halogens or simple alkyl groups at the 4-position instead of sulfur -- have no documented fatalities from the compound alone, no MAO interaction, and predictable dose-response curves. The sulfur atom is the toxicological dividing line in this family.
Absolute Contraindications
- MAOIs (prescription and herbal, including ayahuasca and Syrian rue)
- SSRIs, SNRIs, triptans
- MDMA and other serotonin-releasing agents
- DXM (dextromethorphan)
- Lithium
- Stimulants (amphetamines, cocaine, cathinones)
- Tramadol
- Pre-existing cardiovascular disease
Addiction Potential
2C-T-2 carries negligible addiction potential. It acts primarily through serotonin 5-HT2A agonism, a mechanism that does not produce the dopaminergic reinforcement underlying compulsive use of stimulants, opioids, or alcohol. The experience is intense, involves significant physical discomfort (particularly nausea), and lasts long enough that most users report no desire to repeat it frequently. Tolerance develops rapidly after a single dose, with substantially diminished effects if redosing is attempted within 48-72 hours. Full tolerance reset requires approximately 7-14 days. Complete cross-tolerance exists with all serotonergic psychedelics, including LSD, psilocybin, mescaline, and other 2C compounds. No physical dependence, withdrawal syndrome, or craving pattern has been documented. The compound is not self-reinforcing in animal models. The danger of 2C-T-2 is not that it creates habitual use -- it is that a single use can produce a medical emergency through acute serotonin toxicity in susceptible individuals or in combination with other substances.
Overdose Information
Recognizing a 2C-T-2 Emergency
2C-T-2 belongs to a family of compounds with documented fatalities. Any adverse reaction beyond expected psychedelic effects should be taken seriously and evaluated for escalation. The critical distinction is between a difficult psychedelic experience (unpleasant but not medically dangerous) and serotonin toxicity or cardiovascular crisis (potentially fatal).
Signs that indicate a medical emergency (call emergency services):
- Body temperature above 39°C (102°F) and rising
- Sustained heart rate above 150 bpm, especially with chest pain or irregular rhythm
- Muscle rigidity, sustained clonus (involuntary rhythmic jerking), or tremor that is worsening
- Seizure of any duration
- Confusion progressing to delirium -- the person cannot recognize where they are or who you are
- Profuse sweating with hot, dry skin (indicates the body has lost the ability to thermoregulate)
- Loss of consciousness
Signs of a difficult but non-emergency psychedelic experience:
- Severe anxiety and panic with intact awareness of surroundings
- Nausea and vomiting (common during the come-up)
- Heart rate elevated but below 130 bpm with no chest pain
- Emotional distress with preserved reality testing
Emergency Response Protocol
- Call emergency services. State: "Possible serotonin syndrome from a serotonergic drug." Provide the substance name, dose, time of ingestion, and any other substances taken. Withholding information puts the patient at risk
- Cool the person aggressively. Serotonin syndrome kills through hyperthermia. Remove clothing. Apply ice packs to armpits, groin, and neck. Mist skin with water and fan. Do not immerse in ice water (this can cause vasoconstriction and paradoxically trap heat)
- Benzodiazepines for agitation and seizures. If available, diazepam or lorazepam can manage agitation and prevent seizure escalation. Do not use antipsychotics (chlorpromazine, haloperidol) -- these can worsen serotonergic crises
- Monitor airway. If unconscious, place in recovery position. Be prepared for CPR
- Document everything. Time of ingestion, dose, route, other substances, progression of symptoms. Paramedics and emergency physicians need this timeline
Managing Psychological Distress
If the person is physically stable but experiencing severe anxiety, panic, or frightening perceptual distortions:
- Reduce environmental stimulation. Dim lights, lower volume, remove crowds
- Speak slowly and calmly. Use their name. Make eye contact. Your composure is the most powerful tool available
- Ground them with simple, concrete questions: "Can you tell me your name? Can you squeeze my hand?"
- Remind them that the experience is temporary and caused by a substance with a known duration
- Do not leave a distressed person alone
- Benzodiazepines, if available and the person can swallow safely, can substantially reduce acute psychological distress
Never hesitate to call emergency services because of legal concerns. Good Samaritan laws protect callers in most jurisdictions.
Tolerance
| Full | almost immediately after ingestion |
| Half | 3 days |
| Zero | 7 days |
Cross-tolerances
Legal Status
In November 2003, the European Council decided that 2C-T-2 shall be subjected by the Member States to control measures and criminal penalties within three months.
Australia: 2C-T-2 is illegal in Australia as of 2005.
Austria: 2C-T-2 is illegal to possess, produce and sell under the SMG (Suchtmittelgesetz Österreich).
Belgium: 2C-T-2 was added to the list of illegal psychotropic substances on Nov 8, 2004.
Brazil: 2C-T-2 is illegal to possess, produce and sell as it is listed on Portaria SVS/MS nº 344.
Canada: 2C-T-2 would be considered Schedule III as it is a derivative of 2,5-dimethoxyphenethylamine.
China: As of October 2015, 2C-T-2 is a controlled substance in China.
Denmark: 2C-T-2 was added to category B of the controlled substances list on August 23, 2003.
Germany: 2C-T-2 is controlled under Anlage I BtMG (Narcotics Act, Schedule I) as of October 10, 1998. It is illegal to manufacture, possess, import, export, buy, sell, procure or dispense it without a license.
Italy: 2C-T-2 was added to the "Tabella 1" in a Jan 11, 2005 Ministry of Health statement.
Japan: 2C-T-2 is controlled as a "Designated Substance" (Shitei-Yakubutsu) by the Pharmaceutical Affairs Law, making it illegal to possess or sell.
Latvia: 2C-T-2 is a Schedule I controlled substance.
The Netherlands: 2C-T-2 was classified as an unregistered pharmaceutical as of April 12, 1999. Unlicensed manufacture, sale, import, trade and possession of this substance can be prosecuted.
Switzerland: 2C-T-2 is a controlled substance specifically named under Verzeichnis D.
United Kingdom: 2C-T-2 is a Class A drug in the United Kingdom as a result of the phenethylamine catch-all clause.
United States: 2C-T-2 is a Schedule 1 drug in the U.S., making it illegal to possess, manufacture, or import.
Responsible use
Volumetric liquid dosing
Research chemical
2C-T-2 (Wikipedia)
2C-T-2 (Erowid Vault)
2C-T-2 (PiHKAL / Isomer Design)
Discussion
2C-T-2 (Bluelight)
Experience Reports (1)
Tips (4)
Clear your schedule for the full duration of 2C-T-2 plus afterglow. Do not plan any obligations, driving, or important decisions for the day. Having a time pressure or commitment hanging over you adds unnecessary anxiety.
If you experience anxiety or thought loops on 2C-T-2, change your physical environment: move to a different room, go outside, change the music, or hold something cold. A change of scenery can instantly shift a difficult headspace.
Start with a low dose of 2C-T-2 if it is your first time. You can always take more next time but you cannot take less once ingested. The difference between a comfortable and an overwhelming experience can be surprisingly small.
Do not combine 2C-T-2 with lithium (seizure risk), tramadol (seizure/serotonin syndrome risk), or cannabis at higher doses unless very experienced. Cannabis dramatically intensifies and can destabilize a psychedelic experience.
See Also
References (4)
- Psilocybin produces substantial and sustained decreases in depression and anxiety — Griffiths et al. Journal of Psychopharmacology (2016)paper
- Neural correlates of the LSD experience revealed by multimodal neuroimaging — Carhart-Harris et al. PNAS (2016)paper
- 2C-T-2 - TripSit Factsheet
TripSit factsheet for 2C-T-2
tripsit - 2C-T-2 - Wikipedia
Wikipedia article on 2C-T-2
wikipedia